Dihydrofolate Reductase Antikörper (AA 2-187)
-
- Target Alle Dihydrofolate Reductase (DHFR) Antikörper anzeigen
- Dihydrofolate Reductase (DHFR)
-
Bindungsspezifität
- AA 2-187
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Dihydrofolate Reductase Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Dihydrofolate reductase protein (2-187AA)
- Isotyp
- IgG
- Top Product
- Discover our top product DHFR Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- Dihydrofolate Reductase (DHFR)
- Andere Bezeichnung
- DHFR (DHFR Produkte)
- Hintergrund
-
Background: Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFRL1.
Aliases: DHFR antibody, DHFRP1 antibody, Dihydrofolate reductase antibody, DYR antibody, DYR_HUMAN antibody, EC 1.5.1.3 antibody
- UniProt
- P00374
- Pathways
- Mitotic G1-G1/S Phases
-